This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Camp4 Therapeutics Corporation. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Rutuja Sudhakar Pai: Innovator in Gene Transcription Modulation
Introduction
Rutuja Sudhakar Pai is a notable inventor based in Charlestown, MA (US). He has made significant contributions to the field of gene transcription modulation. His innovative work focuses on utilizing antisense oligonucleotides to target regulatory RNAs, which has implications for treating diseases linked to aberrant gene expression.
Latest Patents
Rutuja holds 1 patent for his invention titled "Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs." This patent describes methods for modulating gene transcription through the use of antisense oligonucleotides (ASOs) that target regulatory RNAs, including promoter-associated RNAs and enhancer RNAs. These methods are particularly useful for increasing the expression of Carbamoyl-Phosphatase Synthetase 1 (CPS1), which can aid in treating diseases associated with abnormal gene expression.
Career Highlights
Rutuja is currently employed at Camp4 Therapeutics Corporation, where he continues to advance his research in gene therapy and transcription modulation. His work is pivotal in the development of innovative therapeutic strategies aimed at addressing genetic disorders.
Collaborations
Some of Rutuja's coworkers include Alfica Sehgal and Bryan J Matthews, who contribute to the collaborative environment at Camp4 Therapeutics Corporation.
Conclusion
Rutuja Sudhakar Pai is a prominent figure in the field of gene transcription modulation, with a focus on innovative methods that have the potential to transform therapeutic approaches for genetic diseases. His contributions are paving the way for future advancements in this critical area of research.